Hi John and welcome,
My first reaction to your latest PCR result is this - the last 4 results since your 0.05% at 21mths would be considered, certainly by my clinician and expert Lab here in the UK, as showing no significant change.
The apparent change in your last 4 PCR % does not seem to me to be significant enough for you to worry - you are not looking a molecular relapse here, and certainly not a reason for you to worry at the moment. You need to compare more than 1 result - pref. 2 or even 3 consecutive results.
Should your next couple of results show a significant rise - particularly the loss of a zero, then that would be a reason for you and your doctor to seriously consider re-introducing your therapy at the original dose. It's the zeros that are important when PCRs get below 1%...ie. into the molecular world. A reason to be worried would be the loss of a 'log' or 1 zero - which equals a 10 fold increase in BCR-ABL1 transcripts.
To put de-escalation into perspective in patients who have responded well to TKI therapy results from the UK DESTINY trial, (de-escalation to half dose for 12 months, going on to stopping treatment) as well as other stopping trials, showed that a good proportion of these good responders with stable MR3; MR4 and lower PCR results, achieved sustainable TFRs. Of those who had a molecular relapse (not to be confused with disease relapse) after either de-escalation or stopping, all regained their original molecular responses within 4-9months after the reintroduction of their original TKI at full dose.
As David has said, samples need to have enough normal gene transcripts used as controls, if they are to generate a PCR result that is meaningful. At very least, any sample needs to contain at least 10,000 control gene transcripts (copies) such as ABL1, BCR or GUSB.
Labs typically use one of the following normal genes, ABL1, BCR or GUSB, as their control genes in order to measure the amount of abnormal BCR/ABL1 fusion gene transcripts present in any given sample. A PCR result is a ratio of the normal gene transcripts (ABL1, BCR etc.) to the abnormal fusion gene transcripts (BCR-ABL1). A PCR result is a ratio between the two, expressed as a percentage.
Factors that can affect qPCR results.
If a blood sample has been in transit for several days or has been stored for too long after sample collection, the cells it contains will already be in the process of dying as the mRNA (protein) will have started to degrade. This means there is a greater chance of an inaccurate result. Many labs will not report results from samples where the control gene is too low i.e below 10,000 transcripts (copies).
So the main points to consider are:
• The lowest acceptable level for a control gene in any one sample is 10,000 copies (transcripts).
• Test results will show a relative proportion, expressed as a percentage, of how many BCR-ABL1 transcripts are present over the total number of cells analysed in the blood sample.
What may be relevant in your case is that as you have responded very well to therapy, your level of BCR-ABL1 gene transcripts is low:
• A sample taken from a patient who is responding well to TKI therapy is more likely to contain a good amount of the normal ABL1 gene transcripts and a much lower amount of abnormal BCR-ABL1 transcripts. This is because cells containing the abnormal fusion gene will have been killed during therapy and would be very few in numbers compared to the numbers at diagnosis or during the first months of therapy.
Sandy